JW Pharmaceutical Corp (001067) - Total Liabilities

Latest as of September 2025: ₩257.46 Billion KRW ≈ $174.47 Million USD

Based on the latest financial reports, JW Pharmaceutical Corp (001067) has total liabilities worth ₩257.46 Billion KRW (≈ $174.47 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore JW Pharmaceutical Corp (001067) long-term investment share to see how much of total assets are deployed in long-term investments.

JW Pharmaceutical Corp - Total Liabilities Trend (2014–2024)

This chart illustrates how JW Pharmaceutical Corp's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 001067 asset base.

JW Pharmaceutical Corp Competitors by Total Liabilities

The table below lists competitors of JW Pharmaceutical Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Novatti Group Ltd AU:NOV	Australia	AU$102.83 Million
J-Long Group Limited NASDAQ:JL	USA	$1.43 Million
JX Luxventure Limited NASDAQ:JXG	USA	$7.55 Million
NB Private Equity Partners Ltd LSE:NBPE	UK	GBX96.67 Million
Metals Creek Resources Corp V:MEK	Canada	CA$292.49K
Solteq PLC HE:SOLTEQ	Finland	€35.22 Million
Cymat Technologies Ltd. V:CYM	Canada	CA$8.15 Million

Liability Composition Analysis (2014–2024)

This chart breaks down JW Pharmaceutical Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See JW Pharmaceutical Corp balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.51	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.73	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.42	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how JW Pharmaceutical Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for JW Pharmaceutical Corp (2014–2024)

The table below shows the annual total liabilities of JW Pharmaceutical Corp from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩275.11 Billion ≈ $186.44 Million	-27.53%
2023-12-31	₩379.60 Billion ≈ $257.25 Million	-5.62%
2022-12-31	₩402.21 Billion ≈ $272.57 Million	-9.52%
2021-12-31	₩444.51 Billion ≈ $301.24 Million	+30.12%
2020-12-31	₩341.62 Billion ≈ $231.51 Million	-0.44%
2019-12-31	₩343.12 Billion ≈ $232.52 Million	+2.83%
2018-12-31	₩333.68 Billion ≈ $226.13 Million	-7.34%
2017-12-31	₩360.10 Billion ≈ $244.03 Million	-3.91%
2016-12-31	₩374.76 Billion ≈ $253.97 Million	-3.43%
2015-12-31	₩388.07 Billion ≈ $262.99 Million	+5.11%
2014-12-31	₩369.22 Billion ≈ $250.21 Million	--

About JW Pharmaceutical Corp

KO:001067 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$7.03 Million

₩10.38 Billion KRW

Market Cap Rank

#27964 Global

#2061 in Korea

Share Price

₩50200.00

Change (1 day)

+3.83%

52-Week Range

₩41000.00 - ₩61500.00

All Time High

₩131401.16